CeriBell (NASDAQ:CBLL) Sees Unusually-High Trading Volume – Here’s Why

CeriBell, Inc. (NASDAQ:CBLL) saw unusually-strong trading volume on Thursday . 429,632 shares were traded during trading, an increase of 31% from the previous session’s volume of 326,995 shares.The stock last traded at $19.9860 and had previously closed at $20.00.

Wall Street Analyst Weigh In

Several brokerages have commented on CBLL. Canaccord Genuity Group decreased their target price on shares of CeriBell from $28.00 to $25.00 and set a “buy” rating for the company in a report on Tuesday, May 12th. Weiss Ratings upgraded shares of CeriBell from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $22.20.

CeriBell Price Performance

The company has a market cap of $741.73 million, a PE ratio of -11.99 and a beta of 0.77. The stock has a fifty day moving average price of $18.78 and a 200-day moving average price of $19.72. The company has a debt-to-equity ratio of 0.14, a current ratio of 10.44 and a quick ratio of 10.01.

CeriBell (NASDAQ:CBLL) last issued its quarterly earnings results on Monday, May 11th. The company reported ($0.52) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.13). The business had revenue of $26.49 million for the quarter, compared to analysts’ expectations of $26.09 million. CeriBell had a negative net margin of 63.51% and a negative return on equity of 38.19%. On average, equities analysts expect that CeriBell, Inc. will post -1.69 earnings per share for the current year.

Insider Activity at CeriBell

In related news, Director William W. Burke sold 2,207 shares of the firm’s stock in a transaction that occurred on Tuesday, June 30th. The shares were sold at an average price of $19.84, for a total transaction of $43,786.88. Following the completion of the sale, the director directly owned 23,022 shares in the company, valued at approximately $456,756.48. This trade represents a 8.75% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Xingjuan Chao sold 39,000 shares of the business’s stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $18.40, for a total transaction of $717,600.00. Following the transaction, the chief executive officer directly owned 850,347 shares in the company, valued at $15,646,384.80. The trade was a 4.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 350,789 shares of company stock worth $6,887,691. Company insiders own 20.10% of the company’s stock.

Institutional Investors Weigh In On CeriBell

A number of institutional investors have recently modified their holdings of CBLL. Caitong International Asset Management Co. Ltd increased its stake in shares of CeriBell by 3,971.0% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,262 shares of the company’s stock worth $28,000 after acquiring an additional 1,231 shares during the last quarter. Strs Ohio acquired a new stake in CeriBell during the first quarter valued at $27,000. CWM LLC boosted its position in CeriBell by 1,178.5% during the fourth quarter. CWM LLC now owns 1,841 shares of the company’s stock valued at $40,000 after purchasing an additional 1,697 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in CeriBell by 353.8% in the second quarter. Tower Research Capital LLC TRC now owns 2,310 shares of the company’s stock valued at $43,000 after purchasing an additional 1,801 shares in the last quarter. Finally, Larson Financial Group LLC increased its position in CeriBell by 1,403.1% in the 4th quarter. Larson Financial Group LLC now owns 2,871 shares of the company’s stock worth $63,000 after purchasing an additional 2,680 shares during the last quarter.

About CeriBell

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.